A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Facioscapulohumeral Muscular Dystrophy
Trial Locations (12)

3052

Royal Children's Hospital, Melborne

15213

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

20010

Children's National Medical Center, Washington D.C.

27710

Duke Children's Hospital, Durham

28207

Carolinas Medical Center, Charlotte

55454

University of Minnesota, Minneapolis

63110

Washington University, St Louis

95817

University of California - Davis, Sacramento

Unknown

The Children's Hospital at Westmead, Sydney

Alberta Children's Hospital, Calgary

416 85

Queen Silvia Children's Hospital, Gothenburg

NE1 3BZ

Newcastle University, Newcastle upon Tyne

Sponsors
All Listed Sponsors
collaborator

FSH Society, Inc.

INDUSTRY

collaborator

FSHD Global Research Foundation

OTHER

collaborator

Muscular Dystrophy Canada

OTHER

collaborator

aTyr Pharma, Inc.

INDUSTRY

lead

Cooperative International Neuromuscular Research Group

NETWORK